Press Releases
CluePoints Launches Complimentary COVID-19 Risk Management Package for Clinical Studies
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, announced that it has launched a complimentary COVID-19 risk management package available to all at no cost. With the FDA, EMA, PMDA...
Press Releases
Mallinckrodt and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of High-Dose Inhaled Nitric Oxide Therapy for COVID-19 Infection
Mallinckrodt plc , a global biopharmaceutical company, and Novoteris, LLC, a clinical stage medical device and pharmaceutical developer focused on innovative nitric oxide gas applications, announced that the Therapeutic Products Directorate of Health Canada has cleared the companies' joint...
Drug Research
Indian Immunologicals to Lead Research Collaboration to Develop Vaccine for COVID-19
Indian Immunologicals Limited (IIL), a leading vaccines manufacturing company, has announced that the company is going to commence research for developing a vaccine for Corona Virus (COVID-19), the pandemic which has infected more than a million and killed about...
Drug Research
Thermo Fisher Scientific to enhance capacity for COVID-19 testing in India
Thermo Fisher Scientific Inc., the world leader in serving science, is accelerating its efforts with diagnostic testing and vaccine development technologies to effectively manage COVID-19 outbreak in the country.
In India, Thermo Fisher is working closely with the relevant government...
Drug Research
Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19
Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic. The companies will combine expertise to discover and develop fully human neutralizing antibodies targeting SARS-CoV-2 to potentially prevent or treat COVID-19. The mutually exclusive collaboration...
Clinical Trials
APEIRON Biologics InitiatesPhase II Clinical Trial of APN01 for Treatment of COVID-19
APEIRON Biologics AG announced that it has received regulatory approvals in Austria, Germany and Denmark to initiate a Phase II clinical trial of APN01 to treat COVID-19. APN01 is the recombinant form of the human angiotensin-converting enzyme 2 (rhACE2),...
Drug Research
Medicines Discovery Catapult helping advance Covid-19 testing
The Medicines Discovery Catapult will open a new dedicated laboratory at Bruntwood SciTech’s Alderley Park in Cheshire, making it one of the government’s national hubs for Covid-19 testing.
Medicines Discovery Catapult is also helping to co-ordinate the establishment of the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.